In order to assess whether the vorinostat-mediated normalization of DM1 cellular phenotypes is a result of HDAC inhibition or off-target effects, we assessed two other pan-HDAC inhibitors that function similarly to vorinostat. Here, HDAC9 is linked to myotonic dystrophy type 1.